Biomerica Reports Third Quarter Fiscal 2025 Financial Results
Provided By GlobeNewswire
Last update: Apr 15, 2025
IRVINE, Calif., April 15, 2025 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), (the “Company”) a global provider of advanced medical diagnostic and therapeutic products today reported financial results for the third quarter of fiscal 2025 ended February 28, 2025.
Read more at globenewswire.comNASDAQ:BMRA (11/13/2025, 8:19:35 PM)
2.5
-0.02 (-0.79%)
Find more stocks in the Stock Screener
